Back to company

VIAD PHARMA ApS: Financial statements 2019

CVR: 36433892

VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,410,155 and a net result of DKK 554,640 compared with DKK 552,786 the year before. That is an increase of 2.8% compared with the year before. Equity amounted to DKK 668,367. The solvency ratio was 65.2%.

Gross Profit
1,410,155 kr.
Profit/Loss
554,640 kr.
Equity
668,367 kr.
Total Assets
1,025,505 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-1.4 mio.555 t.668 t.-
2018-1.4 mio.553 t.714 t.-
2017-1.5 mio.677 t.761 t.-
2016-1.4 mio.623 t.684 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

VIAD PHARMA ApS: The 2018 annual report is outMay 22, 2019

VIAD PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 1,371,505, and the net result was DKK 552,786.

About VIAD PHARMA ApS

VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity amounted to DKK 236,399.